학술논문

Incidence and Risk Factors for Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients with Systemic Autoimmune Rheumatic Diseases
Document Type
Journal
Source
ARTHRITIS & RHEUMATOLOGY; OCT 2023, 75 p423-p425, 3p. Supplement: 9
Subject
Language
English
ISSN
23265205